Efficacy and tolerability of escitalopram in patients with depression vs depression with comorbid anxiety

被引：0

作者：

Lampousi, E. ^{[1
]}

Stamouli, S. ^{[2
]}

Liakouras, A. ^{[3
]}

Panagoutsos, P. ^{[4
]}

机构：

[1] Naval & Vet Hosp, Psychiat Clin, Athens, Greece

[2] Eginition Univ Hosp, Psychiat Clin, Athens, Greece

[3] Gen Hosp, Psychiat Clin, Korinthos, Greece

[4] Hosp Psychiat, Tripolis, Greece

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷

关键词：

D O I：

10.1016/S0924-977X(07)70518-7

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S355 / S356

页数：2

共 50 条

[21] Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression
Bun'kova, K. M.
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (03): : 29 - 32
[22] Tolerability and safety of escitalopram in randomised controlled trials in major depression and anxiety disorders
Baldwin, D.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S317 - S318
[23] Course of depression in patients with comorbid anxiety disorders
Sherbourne, CD
Wells, KB
JOURNAL OF AFFECTIVE DISORDERS, 1997, 43 (03) : 245 - 250
[24] The efficacy and tolerability of escitalopram in depressed patients with or without concomitant anxiety
Olie, JP
Tonnoir, B
Florea, I
EUROPEAN PSYCHIATRY, 2005, 20 : S143 - S143
[25] Application study on escitalopram comorbid fear and depression
Friede, Michael
Laux, G.
Haerter, M.
NERVENARZT, 2007, 78 : 114 - 115
[26] Depression with comorbid anxiety: Loud and silent depression
Kirby, M
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 38 - 38
[27] Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety. Data from the "Boulenger" study
Chauvet-Gelinier, J-C.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2010, 36 (05): : 425 - 432
[28] Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
Laux, G.
Friede, M.
Mueller, W. E.
PHARMACOPSYCHIATRY, 2013, 46 (01) : 16 - 22
[29] Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine
Boulenger, J. P.
Hermes, A.
Huusom, A. K. T.
Weiller, E.
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 605 - 614
[30] Efficacy and tolerability of escitalopram in anxiety disorders: A review
Pelissolo, A.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (04): : 400 - 408

← 1 2 3 4 5 →